StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

QuidelOrtho's price to sales ratio was 0.3× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.3× to 3.5×, with a median of 1.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.4
2025Dec 31, 20250.7×−0.3
2024Dec 31, 20241.1×−0.5
2023Dec 29, 20231.6×−0.3
2022Dec 30, 20221.9×−1.7
2021Dec 31, 20213.5×–

More QuidelOrtho figures

See a number that looks wrong?